Submitted by Anonymous (not verified) on 4 August 2026 - 15:03
Orphan designation: Infigratinib Treatment of achondroplasia, 19/07/2021 Positive
Source:
Orphan designation: Infigratinib Treatment of achondroplasia, 19/07/2021 Positive